[Treatment of lipodystrophy in patients with human immunodeficiency virus infection].
Paredes
R
R
Servicio de Medicina Interna, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona. rparedes@hosp.santpau.es
Muñoz
J
J
Díaz
I
I
Domingo
P
P
D000728:Androgens / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000009:adverse effects; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D005260:Female; D013006:Growth Hormone / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced / Q000473:pathology / Q000628:therapy*; D008297:Male; D012737:Sex Factors
D000728:Androgens; D019380:Anti-HIV Agents; D013006:Growth Hormone